Arbutus Biopharma Corp
(ABUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,330 | 26,285 | 30,776 | 109,282 | 52,251 |
| Marketable Securities | 86,293 | 99,718 | 116,137 | 46,035 | 71,017 |
| Receivables | 2,409 | 1,776 | 1,352 | 899 | 1,312 |
| TOTAL | $127,316 | $132,027 | $151,139 | $160,661 | $127,704 |
| Non-Current Assets | |||||
| PPE Net | 3,309 | 4,674 | 5,070 | 5,983 | 6,927 |
| Investments And Advances | 0 | 6,284 | 37,363 | 35,688 | 0 |
| Other Non-Current Assets | 1,082 | 1,416 | 1,847 | 2,153 | 2,449 |
| TOTAL | $4,391 | $12,374 | $44,280 | $43,824 | $9,376 |
| Total Assets | $131,707 | $144,401 | $195,419 | $204,485 | $137,080 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,564 | 10,271 | 16,029 | 10,838 | 9,151 |
| TOTAL | $15,618 | $22,487 | $32,857 | $11,221 | $9,541 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,571 | 11,791 | 16,456 | N/A | N/A |
| Other Non-Current Liabilities | 15,860 | 15,896 | 19,711 | 23,825 | 25,573 |
| TOTAL | $18,723 | $15,896 | $25,710 | $23,825 | $25,573 |
| Total Liabilities | $34,341 | $38,383 | $58,567 | $35,046 | $35,114 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 191,480 | 179,492 | 162,571 | 148,642 | 95,584 |
| Common Shares | 1,410,025 | 1,349,821 | 1,318,737 | 1,286,636 | 985,939 |
| Retained earnings | -1,346,572 | -1,276,652 | -1,203,803 | -1,134,347 | -1,045,961 |
| Other shareholders' equity | -48,135 | -48,421 | -50,488 | -48,335 | -48,171 |
| TOTAL | $97,366 | $106,018 | $136,852 | $169,439 | $101,966 |
| Total Liabilities And Equity | $131,707 | $144,401 | $195,419 | $204,485 | $137,080 |